Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hybridoma Technology

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...

Cross-reactivity

Cross-reactivity

B Cell Activation and Differentiation

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Assessment of Alphafold Protein Models for Small-Molecule Ligand Docking versus Co-Folding.

Journal of chemical information and modeling·2026

Same author

The scientific legacy of Martin Karplus from the perspective of his collaborators.

Biophysical journal·2026

Same author

Bias in the AlphaFold3 prediction of ligand-induced domain motion in enzymes.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same author

Toward understanding the drivers of antibody-antigen binding.

Biophysical journal·2026

Same author

Towards Understanding the Drivers of Antibody-Antigen Binding.

bioRxiv : the preprint server for biology·2026

Same author

The Influence of Ligands on AlphaFold3 Prediction of Cryptic Pockets.

bioRxiv : the preprint server for biology·2026

Same journal

From biologics to small-molecule modulators: The evolving landscape of interleukin-targeted therapeutics.

Drug discovery today·2026

Same journal

Targeting the GLP-1 receptor pathways for dual management of obesity and depression.

Drug discovery today·2026

Same journal

Chemical intervention strategies targeting MYC for cancer therapy.

Drug discovery today·2026

Same journal

How many protein pairs can we chemically target?

Drug discovery today·2026

Same journal

From trial-and-error to inverse design: how AI is redefining drug delivery systems.

Drug discovery today·2026

Same journal

Critical evaluation of the key mediators causing life-threatening symptoms during human anaphylaxis.

Drug discovery today·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jan 16, 2026

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

Improving B-cell epitope prediction.

Hao Yu¹, Diane Joseph-McCarthy², Sandor Vajda¹

¹Department of Biomedical Engineering, Boston University, Boston, MA 02215, USA; Department of Electrical and Computer Engineering, Boston University, Boston, MA 02215, USA.

Drug Discovery Today

|October 3, 2025

Summary

This summary is machine-generated.

Predicting antibody binding sites on antigens is crucial for immunology and antibody therapies. Combining AlphaFold 3 with AbEMap significantly improves epitope prediction accuracy compared to other methods.

Keywords:

AbEMap AlphaFold 2 AlphaFold 3 DiscoTope 3.0 SEPPA 3.0 ScanNET antibody epitope machine learning

More Related Videos

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope

Published on: March 24, 2017

Single-cell Screening Method for the Selection and Recovery of Antibodies with Desired Specificities from Enriched Human Memory B Cell Populations

Single-cell Screening Method for the Selection and Recovery of Antibodies with Desired Specificities from Enriched Human Memory B Cell Populations

Published on: August 22, 2019

Related Experiment Videos

Last Updated: Jan 16, 2026

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope

Published on: March 24, 2017

Single-cell Screening Method for the Selection and Recovery of Antibodies with Desired Specificities from Enriched Human Memory B Cell Populations

Single-cell Screening Method for the Selection and Recovery of Antibodies with Desired Specificities from Enriched Human Memory B Cell Populations

Published on: August 22, 2019

Area of Science:

Immunology
Structural Biology
Bioinformatics

Background:

Epitope prediction is vital for understanding immune responses and developing antibody therapeutics.
Current methods are often antibody-agnostic or require complex antibody structures.
Machine learning advancements offer new avenues for epitope prediction.

Purpose of the Study:

To evaluate existing epitope prediction methods.
To assess the performance of combining AlphaFold 3 with AbEMap for antibody-specific epitope prediction.

Main Methods:

Evaluation of popular antibody-agnostic and antibody-specific epitope prediction tools.
Integration of AlphaFold 3 (protein structure prediction) with AbEMap (epitope prediction program).

Main Results:

The combined approach of AlphaFold 3 and AbEMap demonstrated superior performance.
This integrated method significantly outperformed other tested epitope prediction strategies.

Conclusions:

Combining advanced protein structure prediction with specialized epitope mapping tools enhances prediction accuracy.
This integrated approach represents a significant advancement in antibody-specific epitope prediction for therapeutic development.